PRTANasdaq

PROTHENA CORP PUBLIC LTD CO

Pharmaceutical Preparations · L2 · CIK 1559053

Develops novel therapies for devastating neurodegenerative and rare amyloid diseases by targeting protein dysregulation

$432M

Market cap

$9.97

Last close

-0.5%

+9.0%

420K

Volume

Price · last 39 sessions-7.6%

May 4L $7.91 · H $11.19Jun 29

301

Total filings

May 15, 2026

Last filing

12/31

Fiscal year end

Similar companies

Comparable business profile · signals at a glance